A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway
Clinical trial NCT02544997 · COMPLETED
Trial details
- NCT number
- NCT02544997
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2020-02-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.